Persistence of Rubella Antibodies after 2 Doses of Measles-Mumps-Rubella Vaccine

• Published in: The Journal of infectious diseases Vol. 200; no. 6; pp. 888 - 899
• Main Authors: LeBaron, Charles W., Forghani, Bagher, Matter, Lukas, Reef, Susan E., Beck, Carol, Bi, Daoling, Cossen, Cynthia, Sullivan, Bradley J.
• Format: Journal Article
• Language: English
• Published: Oxford The University of Chicago Press 15.09.2009; University of Chicago Press; Oxford University Press
• Subjects: Adolescent; Antibodies; Antibodies, Viral - blood; Biological and medical sciences; Child; Child, Preschool; Congenital rubella syndrome; Dosage; Epidemiology; Female; Fundamental and applied biological sciences. Psychology; Human viral diseases; Humans; Immunization, Secondary; Infectious diseases; Kindergarten education; Male; Measels mumps rubella vaccine; Measles; Measles-Mumps-Rubella Vaccine - immunology; Medical sciences; Microbiology; Risk Factors; Rubella; Rubella virus; Vaccination; Viral diseases; Viral diseases with cutaneous or mucosal lesions and viral diseases of the eye; Viruses; Wisconsin; Wisconsin; Infection; Rubella; Mixed vaccine; Microbiology; Antibody; Viral disease

BackgroundSince 1990, most schoolchildren in the United States have received a second dose of measles-mumps-rubella vaccine (MMR2) at kindergarten entry. Elimination of endemic rubella virus circulation in the United States was declared in 2004. The objective of the current study was to evaluate the...